Article
Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphorylome and Acetylome in Nasopharyngeal Carcinoma Cells
2021-07-20
Abstract excerpt
<title>Abstract</title> <p>Suberoylanilide hydroxamic acid (SAHA), as a famous histone deacetylase (HDAC) inhibitor, has been utilized in clinical treatment for cutaneous T-cell lymphoma. Previously the mechanisms underlying SAHA anti-tumor mainly focused on acetylome. However, the characteristics of SAHA in terms of other protein posttranslational modifications (PTMs) and the crosstalk between various modificati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 718f77f7-fb90-5162-ae3a-e36b39569b04
- DOI
- 10.21203/rs.3.rs-655483/v1
